The Impact of the Drug Quality and Security Act on Compounding Pharmacies Is the Subject of May 13th Seminar in Boston

AGAWAM, MASS. — April 29, 2014 — A seminar focusing on the impact of HR3204 — the Drug Quality and Security Act — on compound pharmacies and manufacturers is the subject of a seminar set for May 13, 2014 in Dedham, Mass., near Boston.

Meeting the new guidelines will require substantial changes for many compounders. The seminar is designed to explain the stepping stones needed to comply with the new legislation as well as review USP <797> in its current state.

The seminar will provide pharmacies and compounders that do business as compounding manufacturers and outsourcing facilities with the knowledge they need to know about how the new regulatory expectations will affect their businesses.

Seminar topics will include:

·         Becoming a compounding manufacturer

·         Manufacturing under cGMP requirements

·         Meeting current USP <797> requirements

The seminar will be presented by Microtest Laboratories, a leader in testing services for the medical device, pharmaceutical, and biotechnology industries, on Tuesday, May 13, 2014, from 9 a.m. to 3 p.m. at the Endicott House in Dedham, Mass., just outside Boston. Registration is at 8:30 a.m. A continental breakfast, break refreshments, and a luncheon are included.

To register, visit http://www.microtestlabs.com/seminar or contact Julie Adamski 1-800-631-1680, ext. 192, or jadamski@microtestlabs.com. Advance registration is $149.

About Microtest Laboratories

Microtest Laboratories is a leader in testing services for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts, USA, the company provides expertise and flexible processes that enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://www.microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680. Follow Microtest Laboratories on Facebook at http://facebook.com/MicrotestLaboratories, on LinkedIn at http://goo.gl/H8ZLnM or on Twitter @MicrotestLabs.

Parenteral Drug Association to Discuss Rapid Micro Systems and Tour Microtest Laboratories on May 6th in Agawam, Mass

AGAWAM, MASS. — April 28, 2014 — The New England Chapter of the Parenteral Drug Association (PDA) will feature “Rapid Micro Systems: A New Tool in Navigating the Stormy Seas of Biological Testing” at a May 6 meeting in Agawam, Mass. The meeting also will include a tour of Microtest Laboratories, a leading provider of life science testing services for pharmaceutical and medical device companies.

Keynote speakers at the meeting will include the following:

Dr. Bradford O. Fanger, Ph.D., field applications scientist at Azbil BioVigilant, will discuss “Reducing Manufacturing Risk with Rapid Microbiological Methods.” In his presentation, Dr. Fanger will provide an overview of rapid microbiological systems, the different types available, and their advantages.

James Gebo, senior research and development scientist, Microtest Laboratories, will review “Evaluation and Implementation of Rapid Microbiological Methods.” His presentation will explore the applications for rapid microbiological systems, review the business case for purchasing the technology, and explain ROI reporting.

The dinner meeting will be held at Kaptain Jimmy’s Restaurant and Distillery, 916 Suffield Street, Agawam. The Microtest tour will leave the restaurant at 4 p.m. Both PDA members and non-members are invited to attend.

To register, visit https://store.pda.org/Meetings/Login.aspx?ID=2273.

About the Parenteral Drug Association

The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide. The New England Chapter was formed in 1988, and represents PDA members from the six New England states: Massachusetts, New Hampshire, Rhode Island, Vermont, Maine, and Connecticut.

About Microtest Laboratories

Microtest Laboratories is a leader in testing services for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts, USA, the company provides expertise and flexible processes that enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://www.microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680. Follow Microtest Laboratories on Facebook at http://facebook.com/MicrotestLaboratories, on LinkedIn at http://goo.gl/H8ZLnM or on Twitter @MicrotestLabs.